HK ASIA HLDGS(01723) plans to change its name to "Evermoon Holdings Limited"
HongKong Asia Holdings Limited (01723) announced that the Board of Directors has proposed to change the company's English name from "HK Asia Holdi...
HK ASIA HLDGS (01723) announced that the board of directors proposed to change the company's English name from "HK Asia Holdings Limited" to "Moon Inc." and to change the Chinese name in the company's dual foreign names from "HK ASIA HLDGS" to "".
Related Articles
The combination of trastuzumab deruxtecan has been approved for the treatment of HER2-positive gastric cancer in China by Daiichi Sankyo/Astrazeneca PLC Sponsored ADR (AZN.US).
Takeda (TAK.US) Class 1 New Drug Alverine Tablets is intended to be included in priority review for use in patients with type 1 narcolepsy.
AstraZeneca PLC Sponsored ADR (AZN.US) announces approval of a new indication for PD-L1 antibody in China for the treatment of endometrial cancer.
The combination of trastuzumab deruxtecan has been approved for the treatment of HER2-positive gastric cancer in China by Daiichi Sankyo/Astrazeneca PLC Sponsored ADR (AZN.US).
Takeda (TAK.US) Class 1 New Drug Alverine Tablets is intended to be included in priority review for use in patients with type 1 narcolepsy.
AstraZeneca PLC Sponsored ADR (AZN.US) announces approval of a new indication for PD-L1 antibody in China for the treatment of endometrial cancer.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
